Research Watch: What Recent Studies Say About Magnesium and Sleep (Late June 2026)

Every week I scan the latest journals so you don't have to. This week, three well-designed human trials on magnesium and sleep landed in my reading queue at the same time, and the findings were coherent enough that I wanted to put them side by side. I've also included a brief note on a 2024 systematic review of NMN supplementation that crossed my desk and felt worth flagging for anyone following the longevity space. As always, I'm reading these as a curious founder at Live 5AM, not as a clinician. Nothing here is medical advice.

Quick Answer: Three human randomized controlled trials published in 2024 and 2025 suggest that magnesium supplementation, in forms including bisglycinate and L-threonate, is associated with modest but statistically significant improvements in sleep onset, sleep quality scores, and daytime alertness in adults with self-reported poor sleep. Effect sizes are small to moderate, and results appear strongest in people with lower baseline dietary magnesium intake.

Study 1: Magnesium Bisglycinate Cuts Insomnia Severity Scores in a 155-Person Trial

Schuster J, Cycelskij I, Lopresti A, and Hahn A ran a randomized, double-blind, placebo-controlled trial enrolling 155 adults aged 18 to 65 who self-reported poor sleep quality. Half received 250 mg of elemental magnesium as magnesium bisglycinate daily for four weeks; the other half received a matched placebo. Sleep was tracked using the Insomnia Severity Index (ISI) at baseline and multiple follow-up points.

The magnesium bisglycinate group showed a statistically significant greater reduction in ISI scores compared to placebo by Week 4. The researchers noted the effect size was small (Cohen's d = 0.2), which is honest and worth sitting with. This is not a dramatic transformation story. What the data does suggest is a real, measurable signal.

The most practically interesting finding came from an exploratory subgroup analysis: participants who reported lower baseline dietary magnesium intake showed notably larger improvements. This is consistent with the hypothesis that supplementation closes a gap rather than adding something on top of an already-adequate supply. If your diet is already magnesium-rich, the marginal benefit appears smaller.

Caveats: Four weeks is a short follow-up window. The ISI is self-reported. And the effect size is small in the full sample, so individual responses will vary widely. The study was published in Nature and Science of Sleep in 2025 (DOI 10.2147/NSS.S524348).

Study 2: Magnesium L-Threonate Improved Both Objective and Subjective Sleep in 21 Days

A 2024 randomized controlled trial by Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, and Gu J enrolled 80 adults aged 35 to 55 with self-assessed sleep problems. Participants were assigned to 1 g per day of magnesium L-threonate or placebo for 21 days in a double-blind, parallel-arm design. Crucially, the researchers tracked both subjective sleep scores (questionnaires) and objective measures (wearable monitoring).

Both subjective sleep quality and objective sleep measures improved significantly in the magnesium L-threonate group versus placebo. Daytime functioning also improved on both subjective and objective measures. One specific finding stands out: the treatment group scored significantly better on the "behavior upon awakening" subscale, which covers alertness, coordination, and balance in the first minutes after waking.

Why this matters: Most sleep supplement studies rely only on questionnaires. The inclusion of wearable-based objective measurements makes this design more robust than the typical self-report study. That said, 80 participants is a modest sample, and 21 days is short. The study was published in Sleep Medicine X in August 2024 (PMID 39252819, PMCID PMC11381753).

Note on the ingredient: The researchers used a specific commercial form of magnesium L-threonate. I'm describing the generic form here because the active compound is the same; Live 5AM does not use this specific branded ingredient in any product.

Study 3: A Crossover Trial Found Magnesium Improved Sleep Duration, Deep Sleep, and HRV

Breus M, Hooper S, Lynch T, and Hausenblas H published a 2024 randomized, double-blind, placebo-controlled crossover pilot trial examining magnesium supplementation (1 g per day) versus placebo in 31 adults with a mean age of around 45. The crossover design is noteworthy: each participant went through both the treatment and the placebo periods (with a two-week washout in between), which controls for individual variation in a way that parallel-arm studies cannot.

Compared to placebo, magnesium supplementation was associated with significant improvements across several outcomes: sleep duration, deep sleep percentage, sleep efficiency, readiness scores, activity balance, and HRV (heart rate variability) readiness. These outcomes came from wearable monitoring, not just questionnaires.

Caveats to be clear about: The sample size here is 31, which qualifies it as a pilot trial. Pilot trials are valuable for generating hypotheses and checking feasibility, but they are not large enough to draw firm conclusions. The crossover design is a methodological strength, but the small N limits how far the findings generalize. Consider this a promising signal that needs replication in larger cohorts. Published in Medical Research Archives, 2024 (MRAJ 12(7)).

Bonus Research Note: NMN and Physical Performance in Older Adults

A systematic review published in Cureus in August 2024 by Wen J, Syed B, Kim S, Shehabat M, Ansari U, Razick DI, Akhtar M, and Pai D pooled data from 10 randomized controlled trials involving 437 participants (mean age 58 years, mean follow-up 9.6 weeks). NMN dosages across the included trials ranged from 150 to 1200 mg per day.

The review found that NMN supplementation was positively associated with physical performance outcomes and was well tolerated across all dosages studied. Specific metrics that appeared in the underlying trials included walking distance on a six-minute walk test and measures of muscle function. Blood NAD+ levels were also elevated in the NMN groups in the trials that measured them.

Context: Systematic reviews aggregate existing data; they do not generate new data. The quality of a meta-analysis depends on the quality of the underlying studies, and the 10 trials here varied in design, population, and duration. Still, the overall signal across 437 participants is encouraging for anyone interested in NAD+ precursor research. The review is available at PMCID PMC11365583.

What This Means for Your Routine

Taken together, the three magnesium and sleep studies tell a consistent story: magnesium supplementation, in well-absorbed forms, appears to support sleep quality in adults who are not sleeping well. The effects are not dramatic on a population level, but they are real and they replicate across different study designs, different magnesium forms, and different outcome measures.

A few practical takeaways from this week's reading:

First, dietary intake context matters. If your diet regularly includes leafy greens, legumes, nuts, and seeds, your baseline magnesium status may already be adequate, and the marginal benefit of supplementation may be smaller. If your diet is lower in these foods, the research suggests a larger potential benefit.

Second, form appears to matter. Bisglycinate and L-threonate are both chelated forms with favorable absorption profiles. These are not the same as poorly absorbed oxide forms commonly found in cheap supplements.

Third, the NMN research is heading in an interesting direction for those in the 40-plus age group thinking about physical vitality and cellular energy. The 2024 systematic review is not the end of that conversation, but it is a meaningful checkpoint.

If you're curious about magnesium specifically as a sleep support tool, Live 5AM's Magnesium Bisglycinate 200mg uses the same form studied in the Schuster et al. 2025 trial above. We don't make medical claims about it, but we do think the underlying science on this form is worth understanding.

Frequently Asked Questions

Does magnesium actually help with sleep, or is this marketing?

The recent human trial data does support a real, if modest, association between magnesium supplementation and improved sleep quality scores in adults with self-reported poor sleep. Three randomized controlled trials published in 2024 and 2025 found statistically significant improvements in measures like insomnia severity, sleep duration, and objective wearable data. The effect sizes are small to moderate, meaning results vary across individuals. People with lower baseline dietary magnesium intake appear to respond more noticeably.

What magnesium form is best for sleep support based on current research?

Recent trials have studied magnesium bisglycinate (250 mg elemental magnesium daily) and magnesium L-threonate (1 g daily) specifically in sleep-related outcomes, and both showed positive signals. Both are chelated forms, meaning the magnesium is bound to an amino acid, which is associated with better gastrointestinal tolerance and absorption compared to oxide or sulfate forms. The right choice likely depends on individual tolerance and dietary context rather than one form being definitively superior to the other.

How long does magnesium take to work for sleep?

In the 2025 bisglycinate trial, significant improvements in insomnia severity scores appeared by Week 4. In the 2024 L-threonate trial, improvements in both subjective and objective sleep measures were observed over 21 days. The crossover pilot also used two-week treatment periods. So the research suggests a window of two to four weeks before expecting measurable changes, though individual timelines vary. None of these studies were designed to determine minimum effective duration.

What did the NMN systematic review actually find?

A 2024 systematic review pooling data from 10 randomized controlled trials and 437 participants found that NMN supplementation was positively associated with physical performance outcomes, including walking distance and muscle function measures, in adults with a mean age of 58 years. It was also well tolerated across dosages from 150 to 1200 mg per day. This is a pooled analysis of existing trials, not a single new study, so the findings reflect an aggregate picture rather than a definitive conclusion.

Should I take magnesium if I already eat well?

The 2025 bisglycinate trial found that the strongest responses to supplementation appeared in participants with lower baseline dietary magnesium intake. If your diet is consistently rich in magnesium-containing foods like pumpkin seeds, almonds, dark leafy greens, and legumes, your baseline status may already be sufficient and the marginal benefit of a supplement could be smaller. If you're uncertain about your dietary intake, a conversation with your healthcare provider is a reasonable starting point before adding any supplement.

The Bottom Line

Three rigorous human trials published in 2024 and 2025 point in the same direction: magnesium supplementation in well-absorbed forms is associated with meaningful, though modest, improvements in sleep quality in adults who aren't sleeping well. The effects show up in self-reported questionnaires and in objective wearable data. The people who seem to benefit most are those who weren't getting enough magnesium from food to begin with.

On the NAD+ side, a 2024 systematic review of 10 trials adds to a growing body of evidence suggesting NMN may support physical performance and vitality in older adults. The research is still maturing, but the direction is consistent.

Neither of these areas is settled science. But the volume and consistency of recent human trial data is notable, and I think it warrants attention from anyone who takes their sleep and long-term vitality seriously.

This post is for informational purposes only and does not constitute medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease or health condition. Consult your healthcare provider before starting any new supplement, particularly if you have a medical condition or take prescription medications.

Sources

1. Schuster J, Cycelskij I, Lopresti A, Hahn A. "Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial." Nature and Science of Sleep. 2025. DOI: 10.2147/NSS.S524348. PMCID: PMC12412596.
2. Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, Gu J. "Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial." Sleep Medicine X. 2024 Aug 17;8:100121. PMID: 39252819. PMCID: PMC11381753.
3. Breus M, Hooper S, Lynch T, Hausenblas H. "Effectiveness of magnesium supplementation on sleep quality and mood for adults with poor sleep quality: a randomized double-blind placebo-controlled crossover pilot trial." Medical Research Archives. 2024;12(7).
4. Wen J, Syed B, Kim S, Shehabat M, Ansari U, Razick DI, Akhtar M, Pai D. "Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials." Cureus. 2024 Aug 1. DOI: 10.7759/cureus.65961. PMCID: PMC11365583.